The ozone controversy
Despite many years of accumulated anecdotal evidence, the use of ozone in
medicine remains a controversial issue,
particularly in the United States, with some doctors deriding it as a quack
medicine, “a toxic gas no better than snake oil”, which has no evidence base to
prove its efficacy. On the other hand there are many ozone therapists – Germany
has a strong contingent – who have been practising ozone therapy for many years
on thousands of patients with remarkable results, results that really should
make the orthodox medical establishment sit up and take notice.
In this issue we speak to internationally renowned New York-based ozone
therapist Dr Gerard Sunnen, who believes his study in Egypt to check the
efficacy of ozone on HCV patients was squashed by large corporate interests
(page 28). Unable to patent ozone, their considerable financial interests in the
current regimen of HCV medications would be threatened by positive results from
such a study.
We also publish a paper by Dr Sunnen on the benefits of using ozone to heal
diabetic lesions (page 38).
In the orthopaedics section we speak to Dr Desmond Kwok (page 44), a specialist
spinal surgeon, who outlines the challenges he faces and provides advice on how
to overcome them.
Médecins Sans Frontières, in their regular column (page 64), praises the recent
landmark decision by an Indian court to rule against the challenge by the
powerful drugs company Novartis, and uphold India’s Patents Act, which will
allow the continued manufacture of inexpensive generic drugs upon which many of
the world’s poor rely for their medication.
You will find many other interesting and useful articles – diet advice to give
patients during Ramadan (page 27), product news (page 68) and an interview with
Waseel, a home-grown Saudi company who are ambitiously building the digital
backbone for the burgeoning health insurance industry.